Presentation THT 2026

Hemodynamic-Guided V-A ECMO Management For Cardiogenic Shock: Insight From Initial Experience From TWEET-1 Prospective Registry (To Wean An Ecmo Trials)

Presenter: Sriram Nathan

March 04, 2026

REGISTER for free or LOG IN to view this content

THT 2026

Up Next

Presentation THT 2026

Clinical Feasibility Study of the Magenta Elevate™ percutaneous Left Ventricular Assist Device (pLVAD) System in Patients with Cardiogenic Shock (ELEVATE™ CS FIH)

Presenter: David Israeli

March 04, 2026

More slides +

Presentation THT 2026

Early Feasibility Study Of Using Venous Waveform Analysis To Estimate Right Atrial Pressures In Patients Going For Right Heart Catheterization

Presenter: Bret Alvis

March 04, 2026

Presentation THT 2026

Mi-VAD: The 4th Generation Ventricular Assist Device - moving away from the apical cannulation paradigm: LVAD, RVAD and biventricular assist. Finally the prospect of universal cardiac support

Presenter: Sudhir Kushwaha

March 04, 2026

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.